Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not

Epidemiology and Infection

Volumn 120, Issue 1, 1998, Pages 93-99

  Ossewaarde, J M ^a   Feskens, E J M ^a   De Vries, A ^a   Vallinga, C E ^a   Kromhout, D ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY;

AGED; ARTICLE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY RISK; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; HELICOBACTER PYLORI; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHUMAN;

AGED; CASE-CONTROL STUDIES; CHLAMYDIA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; COHORT STUDIES; CORONARY DISEASE; CYTOMEGALOVIRUS INFECTIONS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; NETHERLANDS; PREVALENCE; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES;

EID: 0031884191     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268897008303     Document Type: Article

References (28)

1. Grayston JT, Wang SP, Kuo CC, Campbell LA. Current knowledge on Chlamydia pneumoniae, Strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis 1989; 8: 191-202.
2. Saikku P, Leinonen M, Mattila K, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988; ii; 983-5.
3. Saikku P, Leinonen M, Tenkanen L, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study. Ann Int Med 1992; 116: 273-8.
4. Shor A, Kuo CC, Patton DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992; 82: 158-61.
5. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 1995; 8; 451-61.
6. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. B M J 1995; 311: 711-4.
7. Mendall, MA, Patel P, Ballam L, Stracham D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross-sectional study. B M J 1996; 312: 1061-5.
8. Melnick JL, Adam E, DeBakey ME. Cytomegalovirus and atherosclerosis. BioEssays 1995; 17: 899-903.
9. Keys A, Aravanis C, Blackburn HW, et al. Epidemiological studies related to coronary heart disease: characteristics of men aged 40-59 in seven countries. Acta Med Scand 1967; Suppl.: 1-392.
10. Weijenberg MP, Feskens EJM, Kromhout D. Total and high density lipoprotein cholesterol as risk factors for coronary heart disease in elderly men during 5 years of follow-up. The Zutphen Elderly Study. Am J Epidemiol. 1996; 143, 151-8.
11. Rose GA, Blackburn H. Cardiovascular survey methods. Geneva: World Health Organization, 1968.
12. Sorlie PD, Cooper L, Schreiner PJ, Rosamond W, Szklo M. Repeatability and validity of the Rose questionnaire for angina pectoris in the Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1996; 49: 719-25.
13. Ossewaarde JM, Manten JW, Hooft HJ, Hekker AC. An enzyme immunoassay to detect specific antibodies to protein and lipopolysaccharide antigens of Chlamydia trachomatis. J Immunol Meth 1989; 123: 293-8.
14. Ossewaarde JM, De Vries A, Van den Hoek JAR, Van Loon AM. Enzyme immunoassay with enhanced specificity for detection of antibodies to Chlamydia trachomatis. J Clin Microbiol 1994; 32, 1419-26.
15. Ladany S, Black CM, Farshy CE, Ossewaarde JM, Barnes RC. Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR). J Clin Microbiol 1989; 27: 2778-83.
16. Plata JC, Leiva J, Martinez J, Navarro JM, Rosa Fraile de la M. Detection of circulating immunocomplexes in patients diagnosed with acute brucellosis. Serodiagn Immunother Infect Dis 1994; 6: 145-8.
17. Saikku P. Chlamydia pneumoniae and cardiovascular diseases. Clin Microbiol Infect 1996; 1 Suppl. 1: S19-S23.
18. Valtonen VV. Infection as a risk factor for infarction and atherosclerosis. Ann Med 1991; 23: 539-43.
19. Ward ME. The immunobiology and immunopathology of chlamydial infections. APMIS 1995; 103: 769-96.
20. Kuo CC, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad USA 1995; 92: 6911-4.
21. Ossewaarde JM, Van Steenbergen JE, Van der Meijden-Kuypers HL, Gorissen WHM. Seroepidemiology of Chlamydia pneumoniae infections in the city of Utrecht, The Netherlands. Atherosclerosis 1995; 115 (Suppl.): S122.
22. Craig WY. Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology. J Clin Lab Analysis 1995; 9; 70-4.
23. Lopes-Virella MF. Interactions between bacterial lipopolysaccharides and serum lipoproteins and their possible role in coronary heart disease. Eur Heart J 1993; 14 Suppl. K: 118-24.
24. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today 1995; 16: 27-33.
25. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-9.
26. Morgando A, Sanseverino P, Perotto C, Molino F, Gai V, Ponzetto A. Helicobacter pylori seropositivity in myocardial infarction. Lancet 1995; 345: 1380.
27. Liston R, Pitt MA, Banerjtee AK. IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients. Lancet 1996; 347: 269.
28. Weijenberg MP, Feskens EJM, Kromhout D. White blood cell count and the risk of coronary heart disease and all-case mortality in elderly men. Arterioscler Thromb Vasc Biol 1996; 16: 499-503.